Treatment options for Secondary Triple Negative Breast Cancer
“I want to be defined by what I am, not by what I am not” – Dr. Steven Isakoff. In the fourth blog of our partnership with Make2ndsCount, we explore the the science behind Triple Negative secondary Breast Cancer (TNBC), as well as current and future treatments available.
Untangling monoclonal antibodies – Trastuzumab, Pertuzumab, Atezolizumab
We know that drug names can be confusing. That’s why we’re untangling drug terminology. Starting with the monoclonal antibodies (AKA the mabs).
Triple Negative and Me: TNBC and its treatments
If you have Triple Negative breast cancer, find out exactly what triple negative is and how it can affect your treatment plan.